Chemosensitivity of In Vitro Colony Forming Units as a Predictor of Response to Antileukemic Drugs
Leukemia is a clonal disease secondary to malignant transformation of one or more normal hematopoietic stem cells. These leukemic stem cells are capable of proliferation and self renewal. They give rise to one or more dominant clones of cells that eventually fill the bone marrow and suppress normal hematopoiesis in the patient. At this time clinical disease becomes apparent with signs and symptoms of marrow failure. The population of blasts in acute leukemia contains cells capable of colony formation in culture [1–6]. These cells are called leukemic colony forming units, L-CFU. If the colonies are harvested from culture and replated, some also contain cells capable of forming colonies so that proliferation of stem cells capable of self renewal can be demonstrated. There is substantial evidence that L-CFU which replicate extensively in vitro and form large colonies are identical or closely related to the leukemic stem cell responsible for maintenance of the leukemic clone in the patient [7, 8].
KeywordsAgar Interferon Melphalan Resis Thiol
Unable to display preview. Download preview PDF.
- 10.Von Hoff DD, Cowan J, Harris G, Reisdorf G: Human tumor cloning: feasibility and clinical correlations. Can Chemo Pharm 6:265–271, 1981.Google Scholar
- 11.Selby P, Buick R, Tannock I: A critical appraisal of the ‘human tumor stem-cell assay’. N Engl J Med 308:129–134, 1983, 1983.Google Scholar
- 22.Buick RN, Izaguirre CA, McCulloch EA: Self-renewal of leukemic blast progenitors as a target for therapeutic intervention. In: Maturation factors and cancer, Moore MAS (ed). New York, Raven Press, 1982, pp 293–298.Google Scholar
- 25.DiPesio JF, Brennan JK, Lichtman MA, Abboud CN, Kirkpatrick FH: The fractionation, characterization and subcellular localization of colony stimulating activities released by the human monocyte-like cell line GCT. Blood 56:717–727, 1980.Google Scholar
- 43.Elliot EM, Ling V: Selection and characterization of Chinese hamster ovary cell mutants resistant to melphalan (L-phenylalanine mustard). Cancer Res 41:393–400, 1981.Google Scholar
- 47.Preisler HD and 12 others: Prediction of response of patients with acute nonlymphocytic leukemia to remission induction therapy: Use of clinical measurements. Brit J Haemat, 1985.Google Scholar
- 52.Taetle R, Guittard JP, Mendelsohn JM: Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglanding E in chronic myeloproliferative disorders. Exp Hematol 8:1190–1201, 1980.Google Scholar
- 56.Preisler HD: Therapy for patients with acute myelocytic leukemia who enter remission: bone marrow transplantation or chemotherapy. Cancer Treat Reports 66:1467–1473, 1982.Google Scholar
- 58.Findley HW, Steuber CP, Ruymann FB, Culbert S, Ragab AH: The effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias. Experimental Hematology, 1985.Google Scholar
- 59.Goldberg J, Zamkoff KW, Nelson DA, Davey FR, Gottlieb AJ: The in vitro effects of vincristine on peripheral blood leukocyte progenitor cells (CFU-C) in patients in blast crisis of chronic granulocytic leukemia: correlation with clinical response. Am J Hemat 14:149–157, 1983.PubMedCrossRefGoogle Scholar